Evaluation of angiotensin converting enzyme 2 (ACE2), angiotensin II (Ang II), miR-141-3p, and miR-421 levels in SARS-CoV-2 patients: a case-control study

Ehsan Kakavandi,Kaveh Sadeghi,Mohammad Shayestehpour,Hossein Mirhendi,Abbas Rahimi Foroushani,Talat Mokhtari-Azad,Nazanin Zahra Shafiei Jandaghi,Jila Yavarian
DOI: https://doi.org/10.1186/s12879-024-09310-3
IF: 3.7
2024-04-24
BMC Infectious Diseases
Abstract:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious virus that uses angiotensin converting enzyme 2 (ACE2), a pivotal member of the renin–angiotensin system (RAS), as its cell-entry receptor. Another member of the RAS, angiotensin II (Ang II), is the major biologically active component in this system. There is growing evidence suggesting that serum miRNAs could serve as prognostic biomarkers for SARS-CoV-2 infection and regulate ACE2 expression. Therefore, the aim of this study is to evaluate the changes in the serum levels of sACE2 and Ang II, as well as the expression level of miR-141-3p and miR-421 in SARS-CoV-2 positive and negative subjects.
infectious diseases
What problem does this paper attempt to address?